Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia
Authors
Keywords
Blood, Red blood cells, Biomarkers, Enzyme-linked immunoassays, Lymphocytes, Messenger RNA, Gene expression, Platelets
Journal
PLoS One
Volume 8, Issue 5, Pages e63958
Publisher
Public Library of Science (PLoS)
Online
2013-05-18
DOI
10.1371/journal.pone.0063958
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial
- (2012) Caterina Mariotti et al. MOVEMENT DISORDERS
- A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial
- (2012) David R. Lynch et al. MOVEMENT DISORDERS
- Effects of Erythropoietin on Frataxin Levels and Mitochondrial Function in Friedreich Ataxia – a Dose–Response Trial
- (2011) Wolfgang Nachbauer et al. CEREBELLUM
- Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
- (2011) Arnulf H. Koeppen JOURNAL OF THE NEUROLOGICAL SCIENCES
- Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia
- (2011) Wolfgang Nachbauer et al. MOVEMENT DISORDERS
- Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
- (2011) Chiranjeevi Sandi et al. NEUROBIOLOGY OF DISEASE
- A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design
- (2011) Francesco Saccà et al. PLoS One
- A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia
- (2010) Eric C. Deutsch et al. MOLECULAR GENETICS AND METABOLISM
- Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit
- (2010) Francesco Saccà et al. MOVEMENT DISORDERS
- Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design
- (2010) Lisa S. Friedman et al. MOVEMENT DISORDERS
- Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model
- (2010) Myriam Rai et al. PLoS One
- A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels
- (2009) Hannes Steinkellner et al. ANALYTICA CHIMICA ACTA
- Lateral-flow immunoassay for the frataxin protein in Friedreich’s ataxia patients and carriers
- (2008) John H. Willis et al. MOLECULAR GENETICS AND METABOLISM
- Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial
- (2008) Sylvia Boesch et al. MOVEMENT DISORDERS
- HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
- (2008) Myriam Rai et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now